Risk tolerance and verification capability affect appropriate vendor selection
Compounded meds are not inspected by the FDA, and that lack of quality control means they pose some level of risk, including incorrect dosing, contamination, and the use of expired ingredients
CBO suggests that while there would be some health care savings from increased AOM usage due to a reduction in obesity-related health problems, those savings would not be nearly enough to pay for the increased spending on the drugs themselves
The practical goal is to reduce avoidable contributors: titrate thoughtfully rather than racing to the highest dose, avoid unnecessarily rapid weight loss, prioritize adequate protein, perform resistance training to preserve lean tissue, and monitor for iron, zinc, vitamin D, vitamin B12, vitamin A, and other deficiencies when intake is substantially reduced